科巴胺和铁缺乏症仍然在遗传性出血端膜病症中构成挑战
Marie Carolin Schleupner1, Alexander Röth2, Luise Adam3,4
1VASCERN HHT Reference Centre, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany. MarieCarolin.Schleupner@uk-essen.de.
Scientific reports
|August 4, 2025
概括
真正的可巴胺 (维生素B12) 缺乏症在遗传性出血性长膜炎 (HHT) 患者中并不比一般人群更常见. 然而,低正常水平是常见的,可能与HHT的症状相关.
科学领域:
- 血液学 血液学 血液学
- 胃肠病学 胃肠病学
- 遗传学 是一个遗传学.
背景情况:
- 遗传性出血性长膜炎 (HHT) 是一种遗传性疾病,其特点是血管脆弱,导致频繁出血和贫血.
- 目前的HHT管理侧重于铁含量和替代,可胺 (维生素B12) 测试通常用于慢性贫血.
- 科巴拉在HHT患者中的特定作用和患病率仍未得到充分研究.
研究的目的:
- 调查科巴拉明缺乏症及其相关症状在患有遗传性出血长管病的患者中的流行情况.
- 探索HHT患者中可巴拉明水平与临床表现,包括胃肠病变之间的关系.
主要方法:
- 从2019年7月至2022年11月期间接受治疗的155名HHT患者的数据的回顾性分析.
- 初始可巴拉明水平低于400 pg/ml的患者接受了进一步的诊断测试和症状评估.
- 通过统计分析,确定了巴胺水平,贫血,缺铁和胃肠道病变之间的显著关联.
主要成果:
- 42%的HHT患者是贫血的,45%的科巴拉水平低于400 pg/ml.
- 确定的可巴胺缺乏症很少见 (7名患者),这表明它并不比一般人群更普遍.
- 经常观察到低正常的可巴胺水平 (低于400 pg/ml),并且与胃肠病变有显著的关联 (p=0.027).
- 铁缺乏症很普遍 (59%),其中大多数 (67%) 没有接受铁疗法.
结论:
- 真正的巴胺缺乏症在HHT患者中不成比例地常见.
- 在HHT中,低正常的可巴胺水平很常见,可能与胃肠病变等特定症状有关.
- 对于出现不明原因症状的HHT患者,应考虑对科巴拉明水平进行评估,即使水平不是临界低.
相关概念视频
01:24Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
01:28Esophageal Varices-II: Clinical Features and Management
140
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
140
01:30Vitamins
992
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
992
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
909
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
909
01:24Esophageal Varices-I: Introduction
338
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
338
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K